Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SoraDox: Sorafenib and Doxorubicin in Advanced HCC
NCT01272557Phase 2Unknown
- Start
- Dec 2010
- Primary completion
- Sep 2014
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of doxorubicin in hepatocellular carcinoma (HCC). Status: unknown.
02
Drugs
doxorubicin
03
Conditions
hepatocellular carcinoma (HCC)
Beyond the preview
Go deeper on NCT01272557.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01272557.